Ackermans & van Haaren

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Camlin Fine Sciences Limited is a Mumbai-based company engaged in the research, development, manufacturing, and marketing of specialty chemicals and additive products. With a global presence, it operates in markets across India, Mexico, North America, Europe, and Asia. The company specializes in providing shelf-life extension solutions, which include antioxidants and natural products aimed at enhancing the longevity of food and feed. Its portfolio includes aroma ingredients like vanillin and ethyl vanillin, as well as nutraceutical products derived from fermentation and green extraction sources. Camlin Fine Sciences also produces performance chemicals and various animal nutrition products, such as growth promoters and antimicrobials. The products cater to diverse industries, including food and beverage, agriculture, pharmaceuticals, and petrochemicals. Founded in 1931, the company was previously known as Camlin Fine Chemicals and rebranded in 2011 to reflect its broader focus on specialty chemicals.

AstriVax is focused on developing novel vaccines that address significant challenges in the field of vaccinology. The company aims to create vaccines that minimize cold chain requirements while providing broad and long-lasting protection against a range of viruses and other pathogens. By pursuing initial clinical validation of its platform technology, AstriVax seeks to establish a comprehensive vaccination pipeline to enhance treatment options in the healthcare sector.

Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

MRM Health NV is a biopharmaceutical company based in Ghent, Belgium, that specializes in developing microbiome-based therapeutics for metabolic diseases. Founded in early 2020 as a subsidiary of MRM Technologies, the company collaborates with the Flemish Institute of Biotechnology (VIB) to translate scientific research into practical applications. MRM Health is focused on innovative drug development, particularly its lead candidate MH002, aimed at treating Inflammatory Bowel Disease (IBD), which encompasses conditions such as Ulcerative Colitis and Crohn's disease. Through its research and development efforts, MRM Health seeks to advance therapeutic options based on the human microbiome.

OncoDNA, established by experts with over six decades of combined experience in medical diagnostics, specializes in precision medicine for cancer and genetic diseases. The company offers clinical guidance and real-time monitoring for late-stage cancer patients, aiding clinicians, researchers, and biopharma companies in advancing cancer and genetic disease treatments.

Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Biolectric specializes in the development of biogas installation systems designed to enhance the biogas energy production sector. The company employs a process that microbiologically converts organic material into biogas under anaerobic conditions, without introducing additional organic biological waste. This innovative approach allows clients to lower energy production costs while promoting environmentally friendly energy solutions. By effectively matching supply with demand, Biolectric provides a sustainable and durable energy alternative.

OncoDNA, established by experts with over six decades of combined experience in medical diagnostics, specializes in precision medicine for cancer and genetic diseases. The company offers clinical guidance and real-time monitoring for late-stage cancer patients, aiding clinicians, researchers, and biopharma companies in advancing cancer and genetic disease treatments.